Literature DB >> 3107822

Failure of Ivalon to provide permanent hepatic arterial occlusion.

D L Miller.   

Abstract

Ivalon (polyvinyl alcohol) is a commonly used embolic agent, generally considered to be permanent. In a patient with the carcinoid syndrome, embolization of hepatic metastases with Ivalon failed to produce permanent occlusion, and recurrent tumor was supplied by many of the same small arteries identified on the original arteriogram. Occasionally, Ivalon may have only a temporary occlusive effect. A possible explanation for this phenomenon is proposed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3107822     DOI: 10.1007/bf02577980

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

1.  Experimental observations on short and long-term effects of arterial occlusion with Ivalon.

Authors:  W R Castaneda-Zuniga; R Sanchez; K Amplatz
Journal:  Radiology       Date:  1978-03       Impact factor: 11.105

2.  Convenient preparation of ready-to-use particles in polyvinyl alcohol foam suspension for embolization.

Authors:  A Berenstein; D A Graeb
Journal:  Radiology       Date:  1982-12       Impact factor: 11.105

3.  Therapeutic embolization with long-term occluding agents and their effects on embolized tissues.

Authors:  R I White; J V Strandberg; G S Gross; K H Barth
Journal:  Radiology       Date:  1977-12       Impact factor: 11.105

4.  Role of hepatic arterial embolisation in the carcinoid syndrome.

Authors:  P N Maton; M Camilleri; G Griffin; D J Allison; H J Hodgson; V S Chadwick
Journal:  Br Med J (Clin Res Ed)       Date:  1983-10-01

5.  Control of carcinoid syndrome with hepatic artery embolization.

Authors:  H A Mitty; R R Warner; L H Newman; J S Train; I H Parnes
Journal:  Radiology       Date:  1985-06       Impact factor: 11.105

6.  Catheter and material selection for transarterial embolization: technical considerations. II. Materials.

Authors:  A Berenstein; I I Kricheff
Journal:  Radiology       Date:  1979-09       Impact factor: 11.105

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.